PILOTTO, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 3.375
AS - Asia 3.116
EU - Europa 1.396
SA - Sud America 410
AF - Africa 148
Continente sconosciuto - Info sul continente non disponibili 82
OC - Oceania 5
Totale 8.532
Nazione #
US - Stati Uniti d'America 3.275
SG - Singapore 1.110
CN - Cina 969
VN - Vietnam 393
SE - Svezia 377
IE - Irlanda 360
BR - Brasile 342
HK - Hong Kong 187
TR - Turchia 157
IT - Italia 111
FR - Francia 108
BD - Bangladesh 102
ZA - Sudafrica 90
NL - Olanda 88
DE - Germania 82
CA - Canada 64
FI - Finlandia 59
RU - Federazione Russa 49
GB - Regno Unito 44
IN - India 41
AR - Argentina 24
CI - Costa d'Avorio 24
IQ - Iraq 20
PL - Polonia 19
MX - Messico 18
UA - Ucraina 17
ES - Italia 16
BE - Belgio 14
IR - Iran 13
JP - Giappone 13
PH - Filippine 13
UZ - Uzbekistan 13
PK - Pakistan 12
MA - Marocco 11
CO - Colombia 9
AZ - Azerbaigian 8
TH - Thailandia 8
MY - Malesia 7
PY - Paraguay 7
VE - Venezuela 7
CL - Cile 6
KR - Corea 6
AT - Austria 5
AU - Australia 5
EC - Ecuador 5
ID - Indonesia 5
TN - Tunisia 5
BG - Bulgaria 4
CH - Svizzera 4
CR - Costa Rica 4
HN - Honduras 4
HU - Ungheria 4
IL - Israele 4
LT - Lituania 4
LV - Lettonia 4
LY - Libia 4
PE - Perù 4
RO - Romania 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AL - Albania 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
EU - Europa 3
JO - Giordania 3
KE - Kenya 3
KG - Kirghizistan 3
KH - Cambogia 3
OM - Oman 3
PS - Palestinian Territory 3
AO - Angola 2
BY - Bielorussia 2
DK - Danimarca 2
LB - Libano 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SR - Suriname 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
CV - Capo Verde 1
DM - Dominica 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
KZ - Kazakistan 1
Totale 8.448
Città #
Chandler 580
Singapore 539
Ashburn 488
Dublin 360
Santa Clara 334
San Jose 267
Beijing 238
Hong Kong 179
Ho Chi Minh City 132
Nanjing 129
Izmir 125
Dearborn 114
Dallas 97
Boardman 96
Johannesburg 89
Hanoi 83
Los Angeles 78
Princeton 74
New York 73
Lauterbourg 67
Shanghai 64
Helsinki 43
Moscow 42
Munich 42
Wilmington 42
Shenyang 41
Nanchang 39
São Paulo 36
Kunming 34
Columbus 32
Jiaxing 30
Toronto 28
Hebei 26
Guangzhou 25
Buffalo 23
San Mateo 23
Abidjan 22
Tianjin 21
Da Nang 20
Frankfurt am Main 19
Jinan 19
Kocaeli 19
Changsha 18
The Dalles 18
Council Bluffs 17
London 17
Rome 17
Milan 16
Turku 16
Hefei 15
Montreal 15
Haiphong 14
Seattle 14
Ann Arbor 13
Brussels 13
Hangzhou 13
Fremont 12
Norwalk 12
Phoenix 12
Zhengzhou 12
Baghdad 11
Denver 11
Orem 11
Pune 11
Rio de Janeiro 11
Tashkent 11
Tokyo 11
Warsaw 11
Parma 10
Naples 9
Jacksonville 8
Baku 7
Boston 7
Leawood 7
Ningbo 7
San Francisco 7
Stockholm 7
Atlanta 6
Brasília 6
Can Tho 6
Kuala Lumpur 6
Amsterdam 5
Bangkok 5
Cambridge 5
Changchun 5
Chicago 5
Fortaleza 5
Houston 5
Hải Dương 5
Istanbul 5
Tây Ninh 5
Washington 5
Zanjan 5
Bratislava 4
Bình Phước 4
Caracas 4
Chengdu 4
Edinburgh 4
Mexico City 4
Mumbai 4
Totale 5.365
Nome #
H2-blockers in the treatment of ulcer disease in the elderly 185
710 Gastrin-17 (G-17): A Serological Bio-Marker for Diagnosis of Gastro-Esophageal Reflux Disease (GERD) 165
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers 161
Current concepts in the management of helicobacter pylori infection: The maastricht III consensus report 157
Acid-related disorders in the elderly 155
[Clinical usefulness of endoscopy of the upper digestive tract in the aged] 154
42 OP Potential use of lactoferrin in a 7 days triple therapy for helicobacter pylori eradication: A pilot study 150
RANITIDINA E NIZATIDINA NELL'ULCERA PEPTICA DELL'ANZIANO: STUDIO MULTICENTRICO, IN DOPPIO CIECO, A BREVE TERMINE 149
Efficacy of 5-ASA in the treatment of colonic diverticular disease 147
ASSESSMENT OF SYMPTOMS IN PATIENTS WITH SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE (SUDD) 146
TERAPIA DI MANTENIMENTO PER UN ANNO CON ANTI-H2 NELL'ULCERA PEPTICA DELL'ANZIANO: IMPORTANZA DELLA SINTOMATOLOGIA COME MARKER DI RECIDIVA 145
ASPETTI METODOLOGICI DEL SONDAGGIO GASTRICO 143
A comparison of five maintenance therapies for reflux esophagitis 143
M1261 Recurrence of Diverticulitis in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD) Treated Cyclically With Mesalamine: Result of a Follow-up Study 142
T1651 The Natural History of Gastric Ulcer: A Twenty-Four Years Clinical-Endoscopical Follow-Up 141
PPIs plus H2-antagonists for non-responders GERD patients: A rescue therapy? (a three months pilot study) 140
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 139
Chronic atrophic gastritis (CAG) and Helicobacter pylori infection eradication: A 3 years follow-up 139
Cure of Helicobacter pylori-positive active duodenal ulcer patients: double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy 138
W1235 Efficacy of 5-ASA in the Treatment of Colonic Diverticular Disease: A Systematic Review 137
INFLUENCE OF BMI ON GASTRIC ACID SECRETION IN ACID RELATED DISEASE 137
Compliance with therapy for ulcer disease: clinical experience and review of the literature 136
PA.7 CLINICAL VARIABILITY IN THE PRESENTATION OF THE GASTROESOPHAGEAL REFLUX DISEASE BEFORE THE HP ERA (STUDY FROM 1975 TO 1995) 135
M1260 Effect of Cyclically Long-Term Treatment With Mesalamine in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD): A 5 Years Follow-up Study 134
Cure of Helicobacter pylori-positive active duodenal ulcer patients: a double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. GISU (Interdisciplinary Group for Ulcer Study) 134
Are morphology and composition of gallstones related? An x-ray diffraction study 133
Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation 131
M1262 Baseline Symptoms in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD) 131
Rabepmzole in the treatment of non-responders GERD patients: a prospective six-month study 130
Role of Helicobacter pylori infection on NSAIDs-related upper gastrointestinal bleeding in the elderly 129
LONG-TERM TREATMENT WITH MESALAMINE IN DIVERTICULAR DISEASE: A FIVE YEARS FOLLOW-UP STUDY 129
Cytotoxin-Associated Gene A-Positive Helicobacter pylori infection in the Elderly: Association with gastric atrophy and intestinal metaplasia 123
Clarithromycin for the cure of Helicobacter pylori infection: One or two weeks of treatment 123
The clinical usefulness of serum pepsinogens, specific IgG anti-HP antibodies and gastrin for monitoring Helicobacter pylori treatment in older people 122
Disappearance of gallbladder wall lesions after treatment with ursodeozycolic acid 117
Different lansoprazole (LA) dosages in H. pylori (Hp) eradication therapy: A prospective multicenter randomized study comparing 30 MG B.I.D. vs. 15 MG B.I.D 116
OC.09.2: Appropriateness of PPI Administration in the Elderly: Evaluation of Acid Secretion and Atrophic Gastritis by Means of a Non-Invasive Test 115
Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly. A case-control study 114
PO.1 NERD AND ERD: THE SCENARIO IS CHANGING OVER THE TIME? A 30 YEARS FOLLOW UP STUDY 114
La terapia delle malattie acido-correlate nell'anziano 112
ACIDO N-ACETILNEURAMINICO DOPO PENTAGASTRINA E SECRETINA IN SOGGETTI CON ULCERA DUODENALE E DISPEPSIA NON ULCEROSA 112
One-week H. Pylori eradication therapy Rabeprezole 20 mg bid vs 10 mg bid 111
The cure for Helicobacter pylori ((HP) infection with double or triple omeprazole-based therápies in the elderly: Effects on eradication rate, chronic gastritis and serum anti-HP antibodies and pepsinogens 109
Changes in parietal and mucous cell mass in the gastric mucosa of normal subjects with age: A morphometric study 108
Does Helicobacter pylori infection eradication modify peptic ulcer prevalence? 108
Low dose of clarithromycin in triple therapy for the eradication of Helicobacter pylori: One or two weeks? 107
Rhythm changes of the heart during upper gastrointestinal endoscopy in the elderly 105
The appearance of gord in patients with duodenal ulcer after eradication of Helicobacter pylori (Hp) infection: A 4 year prospective study 104
Antagonism to calcium antagonists [1] 99
The outcome of low and high grade of chronic atrofic gastritis (CAG) after Helicobacter pylori infection eradication: a 3 years follow-up 99
Markers of slow-healing peptic ulcer in the elderly - A study on 1,052 ranitidine-treated patients 97
Treatment options for Helicobacter pylori infection in the elderly 97
Epidemiology of helicobacter pylori resistance to antffiiotics in North East of Italy: A multicenter study 90
Serum pepsinogens A and C in monitoring Helicobacter pylori (Hp) status after the cure: A prospective 4 year study 90
Do concomitant diseases and therapies affect the persistence of ulcer symptoms in the elderly? 89
Prevalence of H. pylori resistance to antibiotics in North-East Italy: A multicentered study 88
Sucralfate gel versus ranitidine in the treatment of gastroesophageal reflux disease: A controlled study 87
GERD with oropharingeal picture: A prospective therapeutical one-year study 86
P.04.25 ROLE OF CYP2C19*17 AND CYP2C19*2 IN THE RESPONSE TO PROTON PUMP INHIBITORS TREATMENT IN PATIENTS WITH ESOPHAGITIS 86
Sucralfate and cisapride in the treatment of duodenogastric reflux and dyspepsia: A randomized study 85
Tauroursodeoxycholic acid in the treatment of biliary dyspepsia 84
Role of proton pump inhibitors in the prevention of upper GI bleeding in elderly acute and chronic NSAID users 84
Helicobacter pylori (Hp) eradication in functional dyspepsia: A prospective randomized 3 year study 83
Long-term clinical outcome of elderly patients with esophagitis: A three year follow-up study 83
The efficacy of two doses of omeprazole for short- and long-term peptic ulcer treatment in the elderly 83
The effect of Helicobacter pylori infection on NSAID-related gastroduodenal damage in the elderly 83
The effect of aging on oro-cecal transit time in normal subjects and patients with gallstone disease 82
Reply 81
Digestive Diseases: Editorial 80
Response to kittisupamongkol 78
Low-doses versus standard-doses of clarithromycin in combination with amoxycillin and rabeprazole for the eradication of H. pylori infection in elderly subjects 74
The long-term clinical outcome of elderly patients with Helicobacter pylori-associated peptic ulcer disease 63
Drug use and upper gastrointestinal tract in the elderly: An epidemiological survey of general practitioners 63
LA TERAPIA DELLA MALATTIA ULCEROSA NELL'ANZIANO: STUDIO PROSPETTICO RANDOMIZZATO CON FARMACI ANTISECRETORI 53
null 10
Totale 8.532
Categoria #
all - tutte 30.819
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.819


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022340 0 0 1 24 31 1 4 35 16 26 43 159
2022/20231.549 151 172 130 145 97 195 8 121 452 6 61 11
2023/2024445 23 49 13 8 37 110 28 40 24 27 44 42
2024/20251.845 38 88 90 79 256 263 81 91 254 156 147 302
2025/20263.185 343 276 306 246 496 209 340 83 372 258 153 103
2026/202789 78 11 0 0 0 0 0 0 0 0 0 0
Totale 8.532